6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist

Area of Science:

• Pharmacology
• Immunology
• Molecular Biology

Background:

• The P2X7 receptor (P2X7) is a critical mediator of inflammation, involved in cytokine release and cell surface molecule shedding.
• Amiloride and its derivatives show partial inhibition of human P2X7, suggesting potential for developing specific antagonists.
• Identifying selective P2X7 antagonists is crucial for modulating inflammatory responses.

Purpose of the Study:

• To screen amiloride-derived compounds for novel P2X7 antagonists.
• To characterize the inhibitory effects of a newly identified compound, 6-Furopyridine HMA (6-FPHMA), on P2X7.
• To assess the species selectivity and potential therapeutic applications of 6-FPHMA.

Main Methods:

• Screening of an amiloride derivative library to identify P2X7 antagonists.
• Characterization of 6-FPHMA using ATP-induced dye uptake and Ca2+ flux assays in various cell lines (HEK293, RPMI8226, T cells).
• Evaluation of 6-FPHMA's effects on cytokine release (interleukin-1β) and ectodomain shedding (CD23).

Main Results:

• 6-Furopyridine HMA (6-FPHMA) was identified as a novel P2X7 antagonist.
• 6-FPHMA non-competitively inhibited ATP-induced dye uptake and Ca2+ fluxes in human, murine, and canine P2X7 expressing cells.
• 6-FPHMA demonstrated cross-reactivity with P2X4 and other P2 receptors, indicating poor selectivity.

Conclusions:

• 6-FPHMA acts as a potent inhibitor of P2X7 across multiple species.
• The lack of selectivity of 6-FPHMA precludes its use as a specific P2X7 antagonist.
• Further investigation into amiloride derivatives for developing selective P2 receptor antagonists is warranted.